Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.

Mohammed Shareef Khan1, Aditya Murthy2, Tausif Ahmed3

  • 1Biopharmaceutics - Biopharmaceutics and Bioequivalence, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Hyderabad, India. mohammedshareefkhan@drreddys.com.

AAPS Pharmscitech
|December 17, 2024
PubMed
Summary

Ocular biopharmaceutics and drug delivery are optimized using ocular compartmental modeling and simulation. This approach enhances understanding of eye physiology and disease for targeted therapies.